BIRD vs JL

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe operational and profitability concerns. Despite a low Price/Book of 0.65 and Price/Sales of 0.21 suggesting potential value, the company is deeply unprofitable with negative margins across all key metrics, including a -51.90% profit margin and -93.02% ROE. Revenue is contracting at -23.30% YoY, and insider selling activity over the past six months signals management's lack of confidence. While analysts have a bullish target price of $14.00, the single analyst coverage, deteriorating fundamentals, and absence of Altman Z-Score due to likely negative retained earnings or equity raise serious distress risks.

J-Long Group presents a dichotomy between strong balance sheet health and deteriorating earnings quality. The Piotroski F-Score of 5/9 indicates a stable financial condition, supported by a very low Debt/Equity ratio (0.18) and strong liquidity. While the stock trades below its Graham Number ($8.23), suggesting defensive value, it exceeds its growth-based intrinsic value ($4.76). The primary concern is the divergence between robust revenue growth (+19.30%) and declining earnings growth (-16.10%), coupled with a severely bearish technical trend.